Nanoform Finland Oyj (FRA:4YL)

Market Cap	63.14M -37.5%
Revenue (ttm)	3.84M +58.2%
Net Income	-21.77M
EPS	-0.26
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,106
Open	0.7410
Previous Close	0.7440
Day's Range	0.7410 - 0.7410
52-Week Range	0.7380 - 1.3200
Beta	n/a
RSI	29.24
Earnings Date	Feb 26, 2026

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP,...

• Industry: Commercial Physical and Biological Research
• Founded: 2008
• Employees: 173
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4YL

Financial Performance

In 2024, Nanoform Finland Oyj's revenue was 3.66 million, an increase of 42.70% compared to the previous year's 2.57 million. Losses were -23.43 million, 12.9% more than in 2023.